Can a new eye test match the gold standard for glaucoma?
NCT ID NCT07765147
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This study compares two visual field tests used to monitor glaucoma: the current standard Humphrey Visual Field Analyzer and the newer iCare COMPASS. About 28 people with glaucoma or related eye conditions will take both tests in the same visit, with the order alternating between participants. Researchers will compare key measurements, like mean deviation and pattern deviation, to see if the iCare COMPASS provides similar accuracy and any practical advantages.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Visual field testing with the iCare COMPASS device compared to the standard Humphrey Visual Field Analyzer
- What this could lead to
- If the iCare COMPASS proves as accurate as the current standard, it could offer a faster or more convenient way to monitor glaucoma and other eye conditions.
- What could go wrong
- This is a small, early-stage comparison study, so results may not apply broadly. The new device might not match the standard's accuracy or could have practical drawbacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA 1, OPEN ANGLE, D (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eugene and Marilyn Glick Eye Institute
Indianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which laser best tames glaucoma pressure?
- Could a single eye implant replace years of glaucoma drops?
- Eye implant could offer long-term pressure control for glaucoma patients
- Glaucoma implant MINIject put to the test in everyday eye clinics
- Glaucoma implant could replace daily eye drops
- Glaucoma supplement trial fizzles: MEMOPTIC study halted early